The annual meeting of the American Academy of Dermatology was held from March 27 to 31 in Denver and attracted clinicians, ...

If you've struggled to get rid of dimply fat in your legs, hips, or arms — despite rigorous dieting and exercise — you may be dealing with more than just stubborn weight. It could be lipedema.

Amgen Inc. (NASDAQ:AMGN) is one of the 7 Most Profitable Value Stocks to Buy Right Now. Amgen Inc. (NASDAQ:AMGN) is one of ...

Visceral fat, which is stored around your stomach, can be especially hard to lose. But implementing certain foods into your ...

On-body injector delivery of subcutaneous teprotumumab achieves clinically meaningful proptosis reduction in phase 3 thyroid eye disease study.

Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S. sales and distribution rights for a ...

Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced details for the next installment of their R&D Spotlight ...

Evidence gaps include limited topline safety granularity, unknown long-term follow-up and retreatment rates, and lack of ...

Amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L), is safe and ...

Amgen AMGN announced positive top-line results from a late-stage study evaluating the subcutaneous (under the skin or SC) ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.